Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Tables)

v3.22.1
NET LOSS PER SHARE (Tables)
3 Months Ended
Mar. 31, 2022
NET LOSS PER SHARE  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following potentially dilutive securities have been excluded from the computation of diluted net loss per share since their inclusion would be antidilutive:

Three Months Ended

March 31, 

    

2022

    

2021

Warrants

 

15,633,825

 

16,450,946

Preferred shares as convertible into common stock

 

1,111,111

 

9,444,444

Stock options

 

6,064,700

 

1,392,964

Total potentially dilutive shares

 

22,809,636

 

27,288,354